↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$47KSold on the market
1Companies
Sep 1, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 202616:38 | Aug 28, 2026 | AVTXAvalo Therapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $20.00 | −679 | 51,776 | -1% | −$14K | ||
| Sep 1, 202616:38 | Aug 28, 2026 | AVTXAvalo Therapeutics, Inc. | Chief Medical Officer | M · Exercise10b5-1 | $8.04 | +679 | 52,455 | +1% | $5K | ||
| Aug 19, 202616:10 | Aug 17, 2026 | AVTXAvalo Therapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $20.00 | −1,000 | 51,776 | -2% | −$20K | ||
| Aug 19, 202616:10 | Aug 17, 2026 | AVTXAvalo Therapeutics, Inc. | Chief Medical Officer | M · Exercise10b5-1 | $12.65 | +1,000 | 52,776 | +2% | $13K | ||
| Aug 12, 202616:10 | Aug 10, 2026 | AVTXAvalo Therapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $20.00 | −679 | 51,776 | -1% | −$14K | ||
| Aug 12, 202616:10 | Aug 10, 2026 | AVTXAvalo Therapeutics, Inc. | Chief Medical Officer | M · Exercise10b5-1 | $8.04 | +679 | 52,455 | +1% | $5K |